We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+3.44%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$103B
AUM Growth
-$8.16B
(-7.4%)
Cap. Flow
-$11.8B
Cap. Flow
% of AUM
-11.46%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
4,113
New
322
Increased
874
Reduced
2,317
Closed
300
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$587M |
| 2 |
UBS Group
UBS
|
+$204M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$177M |
| 4 |
iShares MSCI South Korea ETF
EWY
|
+$159M |
| 5 |
HES
Hess
HES
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$559M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$479M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$329M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$316M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$281M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.17% |
| 2 | Technology | 10.29% |
| 3 | Healthcare | 9.29% |
| 4 | Consumer Staples | 6.63% |
| 5 | Consumer Discretionary | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRS
3426
DELISTED
Bristow Group, Inc.
BRS
| $189K | ﹤0.01% |
24,704
-9,136
| -27% | -$101K |
|
3427
Atara Biotherapeutics
ATRA
$69.5M
| $187K | ﹤0.01% |
533
-617
| -54% | -$238K |
|
|
CDTX
3428
DELISTED
Cidara Therapeutics
CDTX
| $186K | ﹤0.01% |
+1,242
| New | +$172K |
|
|
AGTC
3429
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $186K | ﹤0.01% |
36,554
+9,444
| +35% | +$53K |
|
|
SREV
3430
DELISTED
ServiceSource International, Inc.
SREV
| $185K | ﹤0.01% |
47,787
-1,354
| -3% | -$4.86K |
|
|
AIFU
3431
AIFU Inc
AIFU
$205M
| $184K | ﹤0.01% |
+54
| New | +$188K |
|
3432
ProPetro Holding
PUMP
$1.32B
| $182K | ﹤0.01% |
+13,039
| New | +$175K |
|
3433
IDT Corp
IDT
$1.63B
| $181K | ﹤0.01% |
14,898
-3,648
| -20% | -$47.3K |
|
|
ONIT
3434
Onity Group
ONIT
$336M
| $180K | ﹤0.01% |
4,458
-1,799
| -29% | -$85.4K |
|
|
ZGNX
3435
DELISTED
Zogenix, Inc.
ZGNX
| $180K | ﹤0.01% |
+12,441
| New | +$156K |
|
3436
Alpha and Omega Semiconductor
AOSL
$922M
| $178K | ﹤0.01% |
10,658
-40,252
| -79% | -$715K |
|
3437
Immunic
IMUX
$188M
| $177K | ﹤0.01% |
+153
| New | +$204K |
|
3438
Lantheus
LNTH
$7.03B
| $177K | ﹤0.01% |
+10,030
| New | +$148K |
|
|
RAS
3439
DELISTED
RAIT Financial Trust
RAS
| $177K | ﹤0.01% |
81,277
-33,881
| -29% | -$87.1K |
|
3440
Enova International
ENVA
$6.27B
| $176K | ﹤0.01% |
11,872
-13,675
| -54% | -$193K |
|
|
BOJA
3441
DELISTED
Bojangles', Inc. Common Stock
BOJA
| $176K | ﹤0.01% |
10,845
-18,822
| -63% | -$347K |
|
3442
MediciNova
MNOV
$65M
| $172K | ﹤0.01% |
+32,508
| New | +$182K |
|
|
ECOM
3443
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $171K | ﹤0.01% |
14,824
-1,281
| -8% | -$14.8K |
|
|
AXAS
3444
DELISTED
Abraxas Petroleum Corp
AXAS
| $171K | ﹤0.01% |
5,261
+1,598
| +44% | +$60K |
|
3445
Rapid7
RPD
$643M
| $170K | ﹤0.01% |
+10,074
| New | +$174K |
|
3446
Vera Bradley
VRA
$106M
| $169K | ﹤0.01% |
17,360
-4,405
| -20% | -$38.5K |
|
|
KDNY
3447
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $169K | ﹤0.01% |
2,966
-1,451
| -33% | -$72.8K |
|
|
SHLD
3448
DELISTED
Sears Holding Corporation
SHLD
| $167K | ﹤0.01% |
18,791
-175,481
| -90% | -$1.64M |
|
|
SVA
3449
DELISTED
Sinovac Biotech, Ltd
SVA
| $167K | ﹤0.01% |
24,739
| – | – |
|
3450
Energy Recovery
ERII
$439M
| $165K | ﹤0.01% |
19,977
-1,550
| -7% | -$12.4K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2017 Portfolio in Review
As of Q2 2017, Credit Suisse held 4,113 positions worth $103B, down 7.4% from $111B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $11.8B in Q2 2017, closing 300 positions and reducing 2,317 holdings. Its most notable exit was Yahoo Inc, an estimated $316M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Credit Suisse opened a new position in Altaba Inc worth $587M.
- Credit Suisse's largest Q2 2017 buy was Altaba Inc: 10,781,590 shares worth $587M.
- Credit Suisse added most to UBS Group in Q2 2017, an estimated $204M increase.
- Credit Suisse's biggest Q2 2017 reduction was US Bancorp, cutting an estimated $559M.
- Credit Suisse fully exited Yahoo Inc in Q2 2017, selling an estimated $316M.
- Credit Suisse's ten largest holdings make up 17% of its $103B portfolio in Q2 2017.
- Credit Suisse opened 322 new positions and closed 300 in Q2 2017.
- Credit Suisse's portfolio value fell 7.4% quarter-over-quarter to $103B.
Based on Credit Suisse's 13F filing for Q2 2017, filed 14 Aug 2017.